Lymphatic mapping with intralesional tracer administration in breast carcinoma patients

Cancer

Volumn 88, Issue 11, 2000, Pages 2546-2552

  Doting, M H Edwina ^a   Jansen, Liesbeth ^b   Nieweg, Omgo E ^b   Piers, D Albertus ^a   Tiebosch, Anton T M G ^a   Koops, Heimen Schraffordt ^a   Rutgers, Emiel J Th ^b   Kroon, Bin B R ^b   Peterse, Johannnes L ^b   Valdés Olmos, Renato A ^b   De Vries, Jakob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Axillary dissection; Breast carcinoma; Lymphoscintigraphy; Sentinel lymph node biopsy

Indexed keywords

DISULFINE BLUE; NANOCOLL TC 99M; TRACER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0034212384     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000601)88:11<2546::AID-CNCR17>3.0.CO;2-Q     Document Type: Article

References (42)

1. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Bull 1894-1895;4:297-323.
2. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21.
3. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996;3:233-4.
4. Cascinelli N, Greco M, Bufalino R, Clemente C, Galluzzo D, Della Donne V, et al. Prognosis of breast cancer with axillary node metastases after surgical treatment only. Eur J Cancer Clin Oncol 1987;23:795-9.
5. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990;125: 1144-7.
6. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986;73:580-4.
7. Morton DL, Wen D, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-9.
8. Kapteijn BAE, Nieweg OE, Peterse JL, Rutgers EJTh, Hart AAM, Dongen van JA, et al. Identification and biopsy of the sentinel node in breast cancer. Eur J Surg Oncol 1998;24: 427-30.
9. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
10. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
11. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;226: 645-53.
12. Sobin LH, Wittekind Ch, editors. UICC TNM Classification of malignant tumours. 5th ed. New York: John Wiley and Sons, Inc., 1997.
13. Jansen L, Doting MHE, Nieweg OE, Vries de J, Valdés Olmos RA, Rutgers EJTh, et al. Clinical relevance of sentinel nodes outside the axilla in breast cancer patients. Br J Surg. In press.
14. Keshtgar MRS, Waddington WA, Lakhani SR, Ell PJ. The sentinel node in surgical oncology. 1st ed. Berlin: Springer-Verlag Berlin Heidelberg, 1999:52.
15. Fölscher DJ, Langman G, Panieri E, Theunissen D, Dent DM. Sentinel axillary lymph node: helpful in axillary management in patients with breast cancer? [abstract]. Br J Surg 1997;84:1586.
16. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
17. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23:495-502.
18. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-40.
19. Sandrucci S, Bello M, Danese S, Giai M, Giani R, Danese F, et al. Predictive value of the sentinel node biopsy in axillary staging of T1-T2 breast cancer. A preliminary experience [abstract]. Joint Meeting on Senology, Eur Soc Mastol, 2nd International Conference; March 20-21, 1997.
20. Reuhl T, Kaisers H, Markwardt J, Haensch W, Hohenberger P, Schlag PM. Axillaausraumung bei klinisch nodal-negativem mammakarzinom. Kann die Indikation durch "sentinel node" Nachweis individualisiert werden? Dtsch Med Wochenschr 1998;123:583-7.
21. Krag D, Weaver D, Alex J, Fairbank J. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe [abstract]. Soc Surg Oncol 1994;47:32.
22. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85:991-3.
23. Gill PG, Hall VE, Kirkwood I, Chatterton BE, Coventry B, Vernon-Roberts E. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer [abstract]. Breast 1997;6:225.
24. Crossin JA, Johnson AC, Stewart PB, Turner WW Jr. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 1998;64:666-8.
25. Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-30.
26. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
27. Horgan K, Mancie-Jones B, Madan M, Andrew A, Quinn C. Axillary sentinel node identification in breast cancer with dye injection alone [abstract]. Br J Surg 1998;85(Suppl):51-2.
28. O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
29. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998;339:941-6.
30. Schneebaum S, Stadler J, Cohen M, Yaniv D, Baron J, Skornick Y. Gamma probe-guided sentinel node biopsy - optimal timing for injection. Eur J Surg Oncol 1998;24:515-9.
31. Borgstein PJ, Pijpers R, Comans EF, Diest van PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
32. Chatterjee S, Menon M, Drew PJ, Fox JN, Carleton PJ, Davies TW, et al. Sentinel node biopsy in primary breast cancer: a prospective assessment of two complementary techniques [abstract]. Eur J Surg Oncol 1998;24:615-6.
33. Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998; 82:1704-8.
34. Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 1998;5:315-21.
35. Koller M, Barsuk D, Zippel D, Engelberg S, Ben-Ari G, Papa MZ. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come? Eur J Surg Oncol 1998;24:166-8.
36. Van der Ent FWC, Kengen RAM, van der Poll HAG, Hoofwijk AGM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999;25:24-9.
37. Bass S, Cox C, McCann C, Dupont E, Berman C, Reinigen D. The effects of post-injection massage on the sensitivity of lymphatic mapping in breast cancer [abstract]. Eur J Nucl Med 1999;26(Suppl):S66.
38. Valdés Olmos RA, Hoefnagel CA, Nieweg OE, Jansen L, Rutgers EJTh, Borger J, et al. Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med 1999;26(4 Suppl): S2-10.
39. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-9.
40. Schreiber RH, Pendas S, Ku NN, Reintgen DS, Shons AR, Berman C, et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 1999;6:95-101.
41. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, et al. Sentinel-lymph-node biopsy for breast cancer - not yet the standard of care. N Engl J Med 1998; 339:990.
42. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-81.